About the journal
Hepatic Medicine: Evidence and Research is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,230 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1179-1535
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,230 USD
- Articles in DOAJ
- 198
- Declared review time
- 16 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2010-12-21
- PUBMED · 2010-02-01
- Indexing
- DOAJ · PUBMED
- APC
- 3,230 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
198
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
215
Last recorded publication year
2026
h-index
37
i10-index
115
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2010-12-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 81%
- ORCID iDs in current deposits
- 61%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Hepatic medicine, evidence and research
- Source type
- journal
- NLM unique ID (PubMed)
- 101544801
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Hepatitis C virus research
- Hepatitis C virus research
- Liver Disease and Transplantation
Show all subjects (75)
- Liver Disease and Transplantation
- Hepatitis B Virus Studies
- Hepatitis B Virus Studies
- Hepatitis B Virus Studies
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Drug-Induced Hepatotoxicity and Protection
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Animal Virus Infections Studies
- Helicobacter pylori-related gastroenterology studies
- Organ Transplantation Techniques and Outcomes
- Liver physiology and pathology
- Liver physiology and pathology
- Organ Transplantation Techniques and Outcomes
- Liver Diseases and Immunity
- Liver Diseases and Immunity
- Organ Transplantation Techniques and Outcomes
- Alcohol Consumption and Health Effects
- Pediatric Hepatobiliary Diseases and Treatments
- Drug-Induced Hepatotoxicity and Protection
- Drug-Induced Hepatotoxicity and Protection
- Alcohol Consumption and Health Effects
- Alcohol Consumption and Health Effects
- Diet, Metabolism, and Disease
- Diet, Metabolism, and Disease
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatitis Viruses Studies and Epidemiology
- Gallbladder and Bile Duct Disorders
- Gallbladder and Bile Duct Disorders
- Cholangiocarcinoma and Gallbladder Cancer Studies
- COVID-19 Clinical Research Studies
- Pediatric Hepatobiliary Diseases and Treatments
- Endoplasmic Reticulum Stress and Disease
- COVID-19 Clinical Research Studies
- Pediatric Hepatobiliary Diseases and Treatments
- Endoplasmic Reticulum Stress and Disease
- Colorectal Cancer Treatments and Studies
- Drug Transport and Resistance Mechanisms
- Heart Failure Treatment and Management
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Drug Transport and Resistance Mechanisms
- Pancreatitis Pathology and Treatment
- Ultrasound Imaging and Elastography
- Sepsis Diagnosis and Treatment
- Pancreatitis Pathology and Treatment
- Clinical Nutrition and Gastroenterology
- Drug Transport and Resistance Mechanisms
- Long-Term Effects of COVID-19
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Metabolomics and Mass Spectrometry Studies
- Metabolomics and Mass Spectrometry Studies
- Diet, Metabolism, and Disease
- Thyroid Disorders and Treatments
- Pancreatic and Hepatic Oncology Research
- SARS-CoV-2 and COVID-19 Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- SARS-CoV-2 and COVID-19 Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pancreatic and Hepatic Oncology Research
- Thyroid Disorders and Treatments
Keywords (DOAJ)
- hepatology
- liver
- liver diseases
- hepatic disorders
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ